The PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutations
about
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screeningCotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate CancerRecent Advances and New Strategies in Targeting Plk1 for Anticancer TherapyMouse models of thyroid cancer: A 2015 update.Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosisModeling anaplastic thyroid carcinoma in the mouse.Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer.Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer.PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells.
P2860
Q35797331-1EA393F0-6198-497B-BC9D-AE33CA18272DQ36289531-8BBEDBFC-D63B-45AB-AB8B-92590B3C2CC1Q36386336-F4D88B41-2258-4AC3-9C61-98EC7CD1E38BQ36405539-1941C4E7-DE1C-49DD-9137-125276F83B45Q37376300-DB185579-DC57-4CB8-8670-E7D50A8A91AFQ38270915-E4BB8E21-2B5C-42B0-AEC8-20B9443F8BE3Q38722189-ADA92378-A083-47E5-8F4F-6661FECB8234Q38793115-BF007FEA-3AB8-4006-A329-516363737E70Q39200418-FF46832C-5403-472E-9436-CAF0C402A0A2
P2860
The PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutations
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The PLK1 inhibitor GSK461364A ...... ture of their driver mutations
@en
The PLK1 inhibitor GSK461364A ...... ure of their driver mutations.
@nl
type
label
The PLK1 inhibitor GSK461364A ...... ture of their driver mutations
@en
The PLK1 inhibitor GSK461364A ...... ure of their driver mutations.
@nl
prefLabel
The PLK1 inhibitor GSK461364A ...... ture of their driver mutations
@en
The PLK1 inhibitor GSK461364A ...... ure of their driver mutations.
@nl
P2093
P2860
P356
P1433
P1476
The PLK1 inhibitor GSK461364A ...... ture of their driver mutations
@en
P2093
Antonio Di Cristofano
Kristy S Kang
Marika A Russo
P2860
P304
P356
10.1089/THY.2013.0037
P577
2013-07-25T00:00:00Z